Female infertility, unspecified. Female infertility, unspecified
Conditions
Interventions
Intervention 1: Discontinued of estrogen in luteal phase support in 6 week of pregnancy and fetal heart beat. Intervention 2: No intervention.
Treatment - Drugs
Discontinued of estrogen in luteal phase support in 6 week of pregnancy and fetal heart beat
No intervention
Sponsors
Royan institute, Vice chancellor for research
Eligibility
Sex/Gender
Female
Age
21 Years to 37 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Patients with surplus embryos undergone infertility treatment cycles (e.g. OHSS, inadequate endometrium, surplus frozen embryo from any cause); Age 21-37 years; Normal BMI (18.5 <BMI <30); IVF / ICSI or IVF or ICSI cycles with antagonists or agonists protocols; Frozen embryos on 2-3 days. Exclusion criteria: Endometrial thickness =7mm; Egg Donors; Surrogacy; Male factor infertility with azoospermia; Age <37 years old; Hydrosalpinx; Uterine anomalies; Myoma with a compression effect or submocusa myoma; PGD; Blastocyst embryo transfer, ZIFT and GIFT.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ongoing pregnancy rate. Timepoint: 6 & 12 weeks of pregnancy. Method of measurement: ultrasonography. | — |
Secondary
| Measure | Time frame |
|---|---|
| Estrogen. Timepoint: start using progesterone for luteal support in FET cycle (day 15), the day of embryo transfer, 6 and 12 weeks of pregnancy. Method of measurement: Blood serum level.;Progesterone. Timepoint: start using progesterone for luteal support in FET cycle (day 15), the day of embryo transfer, 6 and 12 weeks of pregnancy. Method of measurement: Blood serum level. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Abdolhoseyn Shahverdi
Royan Institute
Outcome results
None listed